Aquatic Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Aquatic Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$456K	Buy	1,894 +844	+80%	+$185K	0.02%	826
2026 Q1	$199K	Sell	1,050 -1,586	-60%	-$277K	0.01%	988
2025 Q4	$448K	Buy	+2,636	New	+$404K	0.01%	768
2025 Q2	–	Sell	-806	Closed	-$100K	–	1391
2025 Q1	$100K	Buy	+806	New	+$105K	﹤0.01%	1063
2024 Q3	–	Sell	-11,900	Closed	-$1.27M	–	1345
2024 Q2	$1.27M	Sell	11,900 -7,000	-37%	-$770K	0.05%	351
2024 Q1	$2.28M	Sell	18,900 -15,000	-44%	-$1.84M	0.07%	235
2023 Q4	$4.17M	Buy	+33,900	New	+$4.23M	0.11%	194
2023 Q3	–	Sell	-16,500	Closed	-$2.05M	–	1451
2023 Q2	$2.05M	Buy	16,500 +15,100	+1,079%	+$2.03M	0.11%	198
2023 Q1	$205K	Buy	+1,400	New	+$207K	0.01%	578
2022 Q4	–	Sell	-27,800	Closed	-$3.71M	–	1591
2022 Q3	$3.71M	Buy	27,800 +27,100	+3,871%	+$4.12M	0.36%	64
2022 Q2	$109K	Buy	+700	New	+$108K	0.04%	461
2022 Q1	–	Sell	-300	Closed	-$38K	–	1291
2021 Q4	$38K	Buy	+300	New	+$39.4K	0.07%	388

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Aquatic Capital Management's JAZZ Position: Q2 2026 in Review

Aquatic Capital Management increased its Jazz Pharmaceuticals (JAZZ) stake by 80% in Q2 2026, buying an estimated $185K and bringing the position to 1,894 shares worth $456K. The position accounts for 0.02% of the portfolio, ranked #826.

Aquatic Capital Management first reported a position in JAZZ in Q4 2021 and has held it in 12 quarters since. The position peaked at $4.17M in Q4 2023. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Aquatic Capital Management held 1,894 shares of Jazz Pharmaceuticals worth $456K as of Q2 2026.
Aquatic Capital Management bought 844 Jazz Pharmaceuticals shares in Q2 2026, an estimated $185K.
Jazz Pharmaceuticals made up 0.02% of Aquatic Capital Management's portfolio in Q2 2026, its #826 holding.
Aquatic Capital Management first reported a position in Jazz Pharmaceuticals in Q4 2021 and has held it in 12 quarters since.
Aquatic Capital Management's Jazz Pharmaceuticals position peaked at $4.17M in Q4 2023.
641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.